While the SAFE Drugs Act remains under legislative consideration, the FDA and state attorneys general appear to already be implementing more aggressive oversight measures until a more stringent oversight framework is in place
April 8, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
What Makes Semaglutide Effective Initially, semaglutide was approved by the FDA to treat diabetes
Compounding is the process of creating a custom medication to meet the specific needs of a patient or to address a shortage of a commercially available drug
Semaglutide prescribing information includes warnings for issues such as pancreatitis, gallbladder disease, dehydration-related kidney injury, increased heart rate, and low blood sugar when used with insulin or insulin secretagogues
Truy cp ngy 06 thng 08 nm 2024, t Sidharth Sonthalia v cng s